166 related articles for article (PubMed ID: 28698805)
1. MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on
Qian H; Yang C; Yang Y
Cell Death Discov; 2017; 3():17028. PubMed ID: 28698805
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene.
Alderman C; Sehlaoui A; Xiao Z; Yang Y
Tumour Biol; 2016 Oct; 37(10):13941-13950. PubMed ID: 27492455
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD).
Reuland SN; Smith SM; Bemis LT; Goldstein NB; Almeida AR; Partyka KA; Marquez VE; Zhang Q; Norris DA; Shellman YG
J Invest Dermatol; 2013 May; 133(5):1286-93. PubMed ID: 23190898
[TBL] [Abstract][Full Text] [Related]
4. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
De Martino M; Esposito F; Pellecchia S; Cortez Cardoso Penha R; Botti G; Fusco A; Chieffi P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344629
[TBL] [Abstract][Full Text] [Related]
5. MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma.
Liu YX; Bai JX; Li T; Fu XQ; Chen YJ; Zhu PL; Chou JY; Yin CL; Li JK; Wang YP; Wu JY; Yu ZL
Phytomedicine; 2019 Nov; 64():153084. PubMed ID: 31514083
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
Wu Z; Lu B; Li X; Miao W; Li J; Shi Y; Yu W
Clin Exp Pharmacol Physiol; 2018 May; 45(5):444-451. PubMed ID: 29143362
[TBL] [Abstract][Full Text] [Related]
7. miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.
Liu J; Mi B; Wang Y; Shi C; Mi X; Lu Y; Yu P
Oncol Lett; 2018 Jun; 15(6):8303-8310. PubMed ID: 29928320
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
9. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
10. The Tumorigenic Properties of EZH2 are Mediated by MiR-26a in Uveal Melanoma.
Li Y; Zhang M; Feng H; Mahati S
Front Mol Biosci; 2021; 8():713542. PubMed ID: 34381816
[No Abstract] [Full Text] [Related]
11. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
[TBL] [Abstract][Full Text] [Related]
12. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26a modulates transforming growth factor beta-1-induced proliferation in human fetal lung fibroblasts.
Li X; Liu L; Shen Y; Wang T; Chen L; Xu D; Wen F
Biochem Biophys Res Commun; 2014 Nov; 454(4):512-7. PubMed ID: 25451270
[TBL] [Abstract][Full Text] [Related]
15. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
[TBL] [Abstract][Full Text] [Related]
17. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
[TBL] [Abstract][Full Text] [Related]
18. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
19. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
Guo M; Zhao X; Yuan X; Jiang J; Li P
Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
[TBL] [Abstract][Full Text] [Related]
20. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.
Arts N; Cané S; Hennequart M; Lamy J; Bommer G; Van den Eynde B; De Plaen E
PLoS One; 2015; 10(4):e0122517. PubMed ID: 25853464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]